Active surveillance for childhood brain and spinal cord tumours

Last medical review:

Active surveillance means that the healthcare team watches the tumour closely rather than giving other treatments right away. They will use tests and exams to see if a tumour is growing or spreading. Other treatments are given if there are any signs that the tumour is growing or there is a higher risk that the tumour will progress.

This approach helps avoid side effects that can happen with treatments such as surgery or radiation therapy. There is no evidence so far that active surveillance reduces long-term survival compared to other treatments. And there is no evidence that active surveillance has other negative effects if or when your child starts treatment.

Active surveillance may be a treatment option for some types of low-grade brain and spinal cord tumours.

Expert review and references

  • Donna Johnston, MD
  • Nirav Thacker, MD
  • American Society of Clinical Oncology (ASCO) . Cancer.net: Astrocytoma - Childhood. 2021: https://www.cancer.net/.
  • American Society of Clinical Oncology (ASCO) . Cancer.net: Brain Stem Glioma - Childhood. 2021: https://www.cancer.net/.
  • PDQ® Adult Treatment Editorial Board. Childhood Astrocytomas Treatment (PDQ®)–Health Professional Version . Bethesda, MD: National Cancer Institute; 2022: https://www.cancer.gov/.
  • PDQ® Adult Treatment Editorial Board. Childhood Brain Stem Glioma Treatment (PDQ®)–Health Professional Version . Bethesda, MD: National Cancer Institute; 2022: https://www.cancer.gov/.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society